The Journal of pharmacology and experimental therapeutics

Lithium reduces depression and chemotherapy-related brain problems in rats by supporting brain growth and protective pathways

Updated

Abstract

Lithium treatment may mitigate behavioral and neurobiological abnormalities in a doxorubicin-induced rat model of chemobrain.

  • Doxorubicin injections led to depressive-like behaviors and cognitive impairments in rats, accompanied by changes in brain signaling pathways.
  • This model showed reductions in key receptors and proteins associated with neuroplasticity and increased levels of active GSK-3β.
  • Lithium administration improved behavioral and neurochemical outcomes, suggesting a potential protective effect against chemotherapy-related cognitive decline.
  • The findings indicate that lithium may revamp specific signaling pathways, reducing oxidative stress and neuroinflammation linked to chemobrain.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Conflict of interest The authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free